ConductScience.org, home

Trial · NCT00514046

Participant flow27

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudyNOT COMPLETEDVandetanib 100 mg/m^25
Overall StudyNOT COMPLETEDVandetanib: First 100mg/m^2, Then 150mg/m^2, Followed by 100mg0
Overall StudyNOT COMPLETEDVandetanib:First 100mg/m^2, Then 63mg, 42, 21, 42, & 21mg/m^21
Overall StudyNOT COMPLETEDVandetanib: First 100 mg/m^2, Then 70 mg/m^21
Overall StudyNOT COMPLETEDVandetanib: First 100mg/m^2, Then 150mg/m^2, Followed by 200mg0
Overall StudyNOT COMPLETEDVandetanib:First 100mg/m^2, Then 150mg, 100, 150, 100, 150mg1
Overall StudyNOT COMPLETEDVandetanib: First 150mg/m^2, Then 100mg/m^2, Followed by 150mg1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00514046/flow?page=2